Abstract
This review is based on the debates held in Barcelona from 3 July 2012 to 4 July 2012 with the active participation of all authors. The debates were organized by B-Debate (an initiative of Biocat and Obra Social ‘La Caixa’) and Universitat Pompeu Fabra (Barcelona). The event was held within the framework of the European INBIOMEDvision project (funded by the EU Seventh Framework Programme for Research and Technological Development (FP7) under grant agreement no. 270107). In addition, we received support from EU FP7 project no. 200754 (GEN2PHEN) and the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115002 (eTOX) and no. 115191 (Open PHACTS), resources of which are composed of financial contribution from the EU FP7 and in kind contributions from companies of the European Federation of Pharmaceutical Industries and Associations. L.I.F received support from Instituto de Salud Carlos III Fondo Europeo de Desarollo Regional (CP10/00524).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
